The departure of a large chunk of Spruson & Ferguson's legacy leadership could have destabilised the firm, but its fighting ...
Bolar beyond regulatory preparation: EU Pharma Package, Türkiye’s experience, and TRIPS compliance
Selin Sinem Erciyas of Gün + Partners examines whether the EU Pharma Package’s expanded Bolar exemption aligns with the TRIPS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results